Finance

Lists
BALPHARMA:NSE
Bal Pharma Ltd
99,39 ₹
0,00%
(0,00) 1D
14 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALPHARMA...
Open
99,38 ₹
High
101,99 ₹
Low
96,18 ₹
Mkt. cap
1,58 млрд
Avg. vol.
111,31 м.
Volume
4,06 мың
Dividend
1,21%
Quarterly dividend
0,30 ₹
Ex-dividend date
2026 ж. 17 қыр.
P/E ratio
21,91
52-wk high
124,60 ₹
52-wk low
60,00 ₹
EPS
4,54 ₹
Shares outstanding
14,17 млн
No. of employees
939
Open
99,38 ₹
High
101,99 ₹
Low
96,18 ₹
Mkt. cap
1,58 млрд
Avg. vol.
111,31 м.
Volume
4,06 мың
Dividend
1,21%
Quarterly dividend
0,30 ₹
Ex-dividend date
2026 ж. 17 қыр.
P/E ratio
21,91
52-wk high
124,60 ₹
52-wk low
60,00 ₹
EPS
4,54 ₹
Shares outstanding
14,17 млн
No. of employees
939
News stories
From web sources and news partners
About Bal Pharma Ltd
CEO-
Employees939
Founded1987
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
740,25 млн
876,90 млн
840,76 млн
886,16 млн
Cost of goods sold
399,35 млн
461,60 млн
436,91 млн
511,52 млн
Cost of revenue
399,35 млн
461,60 млн
436,91 млн
511,52 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
162,71 млн
173,24 млн
189,03 млн
170,64 млн
Operating expense
306,30 млн
352,15 млн
346,41 млн
322,99 млн
Total operating expenses
705,66 млн
813,74 млн
783,32 млн
834,51 млн
Operating income
34,59 млн
63,15 млн
57,43 млн
51,66 млн
Other non operating income
11,16 млн
3,26 млн
-37,86 млн
4,38 млн
EBT including unusual items
7,17 млн
17,91 млн
32,18 млн
11,38 млн
EBT excluding unusual items
7,17 млн
17,91 млн
31,04 млн
11,38 млн
Income tax expense
-
-
-3,86 млн
-
Effective tax rate
-
-
-12,00%
-
Other operating expenses
120,88 млн
146,61 млн
126,80 млн
124,52 млн
Net income
7,10 млн
17,80 млн
35,94 млн
11,24 млн
Net profit margin
0,96%
2,03%
4,27%
1,27%
Earnings per share
-
-
-
-
Interest and investment income
-
-
9,53 млн
-
Interest expense
-38,58 млн
-48,51 млн
-21,20 млн
-44,66 млн
Net interest expenses
-38,58 млн
-48,51 млн
-11,67 млн
-44,66 млн
Depreciation and amortization charges
22,71 млн
32,30 млн
30,58 млн
27,82 млн
EBITDA
58,55 млн
77,54 млн
72,77 млн
79,35 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары